Run clinical research with less friction and fewer errors.
Nearly 80% of clinical trials miss their original enrollment timeline, and manual information flows — patient identification, data capture, and reporting — are the biggest reason why. Every month of delay adds direct cost, delays results, and increases error and compliance risk.
Value in weeks — measurable impact in months.
First protocol digitized in 8–10 weeks
Portfolio of studies in 4–6 months
- Accelerate enrollment with AI-assisted patient identification and eligibility matching
- Reduce data-capture errors before they reach a regulatory submission
- Automate regulatory reporting so coordinators spend less time on paperwork, more on patients
Faster enrollment alone typically offsets the cost of the platform within the first active protocol.
Capabilities.
Runs on our governed AI platform.
Nova Trials is built on Nova Cortex — our data fabric, concept graph, governed inference, and multi-agent runtime — so it inherits enterprise security, auditability, and the ability for your teams to extend it.
Where it delivers.
Built for your sector.
Enterprise-grade by design.
| Deployment | Private VPC or on-prem — your data never leaves your perimeter |
|---|---|
| Data privacy | No training on your data; no calls to public LLM APIs |
| Access & audit | Policy-based access control (PBAC) and immutable audit logs |
| Model strategy | Model-agnostic — open-weight, commercial, or your own fine-tuned models |
| Integration | RESTful APIs & connectors: AWS, Azure, GCP, SAP, Salesforce, ServiceNow, Snowflake |
| Accuracy & control | RAG + guardrails + human-in-the-loop; deterministic numeric paths, no fabricated numbers |
Nova Cortex is model-agnostic. It runs self-hosted open-weight models (Gemma, Qwen, GLM-class) and can route to commercial or your own fine-tuned models — so you are never locked into a single vendor and can swap models as the market evolves.
- RAG (retrieval-augmented generation) grounded in your data
- Pre- and post-inference guardrails
- Bias and drift monitoring
- Human-in-the-loop on high-stakes decisions
- Deterministic numeric paths — no fabricated numbers
- Every prompt, retrieval, and answer logged and reproducible
A disciplined path to production.
Discovery & Data Audit
We align on your goals, map your data and constraints, and define the highest-ROI use case.
Core Configuration
We stand up your governed Nova Cortex core — data fabric, concept graph, and guardrails — in your environment.
Pilot (Proof of Value)
A working system on your real data, validated against your success metrics and security sign-off.
Scale in Production
Hardened rollout across your operation, with governance, observability, and ongoing support.
A copilot, not a replacement.
Our AI is a copilot, not a replacement. It absorbs the repetitive, administrative work so your people apply judgment, build relationships, and do the work only humans can. We include enablement so teams adopt it with confidence, not fear.
35%+ — faster patient enrollment.
Priced on value, not seats.
Flexible, transparent licensing — priced on the value you use (data volume / usage), with scalable annual contracts and a private-deployment option. No per-seat lock-in. We scope Total Cost of Ownership with you before you commit.
Architecture & Security Whitepaper
The deployment, governance, and compliance detail your CIO, CISO, and architects need — in one document.
Frequently asked questions
Is patient data kept private?
Yes — data is processed and stored under governed, HIPAA-aligned controls, with full audit and access control.
How does AI actually speed up patient enrollment?
Nova Trials matches your protocol's eligibility criteria against patient records in real time, surfacing qualified candidates your coordinators would otherwise find by manual chart review — cutting screening time without lowering the bar on eligibility.
Does this replace our clinical research coordinators?
No — it's a force multiplier. Coordinators still make every enrollment decision; Nova Trials removes the manual chart-review and data-entry work so they can screen more patients and manage more active protocols.
Is Nova Trials validated for GxP / 21 CFR Part 11 environments?
Yes — the platform is built for GxP-ready deployment with immutable audit trails and electronic-record controls aligned to 21 CFR Part 11. We support your validation and qualification process as part of onboarding.
How does this integrate with our EDC, CTMS, or existing systems?
RESTful APIs and connectors for major EDC, CTMS, and enterprise systems — patient, protocol, and reporting data flow into the tools your team already uses, with no duplicate data entry.
How quickly can we go live, and what does a pilot look like?
First protocol digitized in 8–10 weeks, with a full portfolio of studies live in 4–6 months. Pilots typically start with one active protocol before expanding across your study portfolio.
Can Nova Trials work across multiple sites, sponsors, or CROs on the same study?
Yes — the platform is built for multi-site, multi-stakeholder studies, with governed access control so each site, sponsor, or CRO sees only the data they're authorized to see.
How do you prevent AI errors from reaching a regulatory submission?
Nova Trials uses RAG and guardrails with deterministic numeric paths — no fabricated figures — and every AI-assisted output is reviewed and signed off by your clinical research staff before it enters the record.
Where does our data live, and does it ever leave our environment?
Data is processed and stored under governed, HIPAA-aligned controls in a private VPC or on-prem — no training on your data, no calls to public LLM APIs.
How does Nova Trials handle patient diversity and eligibility bias?
Eligibility matching runs against protocol criteria you define, not proxy variables — so it's built to widen your qualified candidate pool without introducing the selection bias manual chart review can create.
What's the ROI case, and how do we measure it?
We target 35%+ faster patient enrollment through AI-assisted identification and matching, and we baseline your current enrollment and error rates with you before the pilot starts, so ROI is measured against your data, not ours.
How is Nova Trials priced?
Priced on the value you use — active protocols and data volume, not per seat — with scalable annual contracts and a private-deployment option. We build the TCO case with you before you commit.
Can this scale across a full portfolio of studies, not just one trial?
Yes. The platform is built for enterprise scale, and onboarding is phased by protocol so you can expand across your study portfolio without disrupting active trials.
What audit and compliance reporting does Nova Trials produce?
Automated, compliance-ready reporting for sponsors and regulators, with an immutable audit trail for every record and every change — built to hold up under inspection.
What do we need to get started?
An active or upcoming protocol, a clinical research sponsor to define eligibility criteria and reporting requirements, and an IT/security contact for EDC/CTMS integration and data governance sign-off. We handle digitization and validation support from there.
See Nova Trials in your operation
Schedule a 30-minute call with our team. We'll show you real deployments, discuss your challenges, and map out a path to results.
Related insights
No content available for this category yet. Check back soon!